OWP
FOLD

Old Well Partners’s Amicus Therapeutics FOLD Stock Holding History

Old Well Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,700
Closed -$180K – 36
2023
Q4 		$180K Buy
+12,700
New +$144K 0.16% 40
2022
Q1 		– Sell
-11,800
Closed -$136K – 37
2021
Q4 		$136K Hold
11,800
– – 0.08% 34
2021
Q3 		$113K Buy
+11,800
New +$121K 0.06% 35

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Old Well Partners's FOLD Position: Q1 2024 in Review

Old Well Partners sold out of Amicus Therapeutics (FOLD) in Q1 2024, closing a stake of 12,700 shares — an estimated $180K sold.

Old Well Partners first reported a position in FOLD in Q3 2021 and held it in 3 quarters. The position peaked at $180K in Q4 2023. 254 funds tracked by Wall St. Rank hold FOLD as of Q1 2024.

  • Old Well Partners reported no remaining Amicus Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Old Well Partners sold 12,700 Amicus Therapeutics shares in Q1 2024, an estimated $180K.
  • Old Well Partners first reported a position in Amicus Therapeutics in Q3 2021 and held it in 3 quarters.
  • Old Well Partners's Amicus Therapeutics position peaked at $180K in Q4 2023.
  • 254 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2024.

Based on Old Well Partners's 13F filing for Q1 2024, filed 15 May 2024.